colloque antibody biosimilars, fears or opportunities?

Official Journal of the Generics and biosimilars Initiative

?? META Description ??

Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars. High end scientific talent, research and development infrastructure. Largest Indian insulins company. Rich pipeline of biosimilars with nine products and novel biologics at various stages of clinical development including a high potential

The Association for Accessible Medicines works to ensure more generic and biosimilar medicines are accessible to more people who need them. 

Building trust in cost-effective treatments

Creative Biolabs, a leading supplier of recombinant antibodies, develops a wide range of antibodies from therapeutic antibodies and single domain antibodies to bispecific antibodies and intrabodies.

Colloque antibody biosimilars, fears or opportunities?

The 5th Antibody Industrial Symposium 2017 (AIS2017) will be held the 27 and 28th of June 2017 in Tours, Loire Valley, France. This congress, jointly organized by the LabEx MAbImprove, Polepharma and MabDesign, is the continuation of the series of Industrial Symposia organized since 2013 (Antibody biosimilars, MAbDosing, MAbDelivery, and Current and Next Generation Antibody Formats).

Biocon is an innovation led fully integrated biopharmaceutical company that developes affordable biosimilars, generic formulations & complex APIs